Abstract BACKGROUND:Studies of the relationship between cortisol and posttraumatic stress disorder (PTSD) have had inconsistent results. Gender, trauma type, and age at trauma exposure may explain the inconsistencies. OBJECTIVE: The objective of the review was to examine cortisol levels in relation to PTSD in women with a history of child maltreatment trauma. DESIGN: A review of literature found 13 articles eligible for inclusion. RESULTS: Despite limiting focus to the relatively homogeneous population, the patterns of associations between PTSD and cortisol levels were still inconsistent. CONCLUSIONS: The reasons for the inconsistencies likely include highly varied methods across studies, small convenience samples, and unmeasured neuroendocrine hormones that may be stronger predictors of PTSD. The review does not point to a clear bio-behavioral target for psychiatric nursing intervention. It is important to continue to address the developmental and clinical stress response aspects of child maltreatment trauma-related PTSD without assuming that these stress responses are hypothalamic-pituitary-adrenal-axis driven.
Introduction
Early disease morbidity occurs in individuals with traumarelated psychopathology including posttraumatic stress disorder (PTSD; Boscarino, 2012; Kessler, Chiu, Demler, Merikangas, & Walters, 2005) . PTSD is frequently comorbid with other psychiatric disorders such as depression and anxiety disorders (Spinhoven, Penninx, van Hemert, de Rooij, & Elzinga, 2014) . It also has been associated with physical health problems, such as general medical conditions, musculoskeletal pain, cardiorespiratory symptoms, gastrointestinal health, and poor quality of life (Pacella, Hruska, & Delahanty, 2013) . Psychiatric nurses would be well positioned to advance bio-behavioral interventions for individuals with PTSD. However, we need better understanding of the underlying pathophysiology to go forward with intervention research.
The hypothalamic-pituitary-adrenal (HPA) axis as one of three major stress response systems (Teicher, Andersen, Polcari, Anderson, & Navalta, 2002) has been suggested in relation to trauma-related psychopathology (Yehuda, Halligan, Grossman, Golier, & Wong, 2002) . When traumatic stress occurs, the HPA axis activity is initiated and cortisol is produced and released to play a significant role in both the stress response and the maintenance of homeostasis (Sapolsky, Romero, & Munck, 2000) . Multiple studies have explored cortisol levels in relation to PTSD. However, in recent four meta-analyses studying associations of cortisol with chronic stress, traumatic stress, and PTSD, patterns of both hyper-and hypocortisolemia have been found, along with findings that there are no differences by PTSD status (Klaassens, Giltay, Cuijpers, van Veen, & Zitman, 2012; Meewisse, Reitsma, de Vries, Gersons, & Olff, 2007; Miller, Chen, & Zhou, 2007; Morris, Compas, & Garber, 2012) .
The confounding factors that might clarify the contradictory findings in research on cortisol and PTSD to date are gender, trauma type, and developmental period of the exposure. Developmental trauma theories suggest that gender, nature of the trauma, and age at exposure to 710313J APXXX10.1177/1078390317710313Journal of the American Psychiatric Nurses AssociationLi and Seng
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1 Yang Li, BS, University of Michigan, Ann Arbor, MI, USA 2 Julia S. Seng, PhD, CNM, University of Michigan, Ann Arbor, MI, USA the trauma are likely to play a part in an individual's response with resilience, PTSD, or complex forms of posttraumatic psychopathology (Bonanno & Mancini, 2012; Cloitre et al., 2009; Ditlevsen & Elklit, 2012; Perry, Pollard, Blakley, Baker, & Vigilante, 1995) . These factors may also affect whether the exposure results in neuroendocrine dysregulations (Boyce & Ellis, 2005) . Women were found to have an increased risk for PTSD compared with men (Kessler, Berglund, et al., 2005) . Two meta-analyses demonstrated sex differences in basal cortisol levels and cortisol stress response (Meewisse et al., 2007; Morris et al., 2012) . Altered HPA axis function may confer increased susceptibility to PTSD in women. Therefore, the influence of gender needs to be considered when examining cortisol as a biomarker of PTSD vulnerability.
In addition, individuals may have a greater vulnerability to the effects of trauma during childhood since childhood is a crucial period for children's development. Women with child maltreatment trauma (CMT) exposure were found to have a greater risk for PTSD (Seng, Low, Sperlich, Ronis, & Liberzon, 2009) . Maltreatment trauma in childhood may have a distinct effect on HPA stress activity compared with trauma exposure during adulthood (Morris et al., 2012) . Thus, controlling for the influence of CMT, may contribute to more consistent findings in terms of the associations between cortisol and PTSD in female population. Given that CMT may impose a significant long-term effect on neuroendocrine function, maltreated women with subsequent PTSD may have a unique cortisol pattern, which could advance our understandings of whether cortisol is associated with the susceptibility to PTSD in women with CMT exposure. The findings could also assist in determining whether other neuroendocrine alterations (i.e., the sexually dimorphic hormone oxytocin, or more complex profiles such as sympathetic to parasympathetic hormone ratios) should be considered as potential biomarkers for this population (Teicher et al., 2002) .
This literature review examines patterns of cortisol levels (basal and challenged) in studies focusing on a large population that is relatively homogenous in terms of gender, trauma-type, and age at exposure-PTSDdiagnosed women with maltreatment trauma that occurred in childhood. We organized our review based on three different designs used in the original reports: (a) comparisons across three groups, including trauma controls and healthy controls; (b) comparisons across two groups, including trauma controls or healthy controls; and (c) examination of PTSD in relation to cortisol, adjusting for CMT. We have two related aims. First, we aim to determine the cortisol patterns in women with PTSD and CMT; second, we aim to determine the cortisol patterns in women with PTSD, adjusting for CMT.
Method

Search Strategy
A comprehensive literature search was conducted in September 2014 using the following electronic databases without date restriction: MEDLINE, PubMed, CINAHL, Web of Science, SCOPUS, and PsyclNFO. Since the earliest relevant literature was published in October 1990, we imposed no restriction on the timeframe. The publication period is between October 1990 and September 2014. The following search terms were used: cortisol, hydrocortisone, PTSD, posttraumatic stress disorder, posttraumatic stress disorder symptoms, child abuse, childhood abuse, child neglect, childhood trauma, child maltreatment, and childhood maltreatment.
Eligibility Criteria
Inclusion criteria were studies published in English, full text available, and included female participants 18 years of age and older. Inclusion criteria were articles that had PTSD-diagnosed women with CMT exposure and either women with CMT exposure only or healthy controls as comparison group or articles that controlled for CMT in analyses when testing the association between cortisol and PTSD. Exclusion criteria were articles that did not measure all three factors: cortisol levels, PTSD, and history of CMT, and that did not include women. Review articles, published abstracts, book chapters, commentaries, letter to the editor, and animal studies were also excluded. These criteria were selected to review studies that assist in determining the specific patterns of cortisol levels in PTSD-diagnosed women with CMT exposure and examining the association between cortisol and PTSD after controlling for CMT.
Study Selection
A single reviewer assessed the titles and abstracts of searched research articles for eligibility and relevance. Decisions on final inclusion after retrieval of articles were made by one reviewer and checked by a second reviewer, and any disagreements were resolved by consensus following discussion with a third reviewer.
Data Collection Process
A single reviewer extracted the data using a data extraction sheet. A second reviewer checked extracted data. The data extracted from each study included author's name, publication date, study design, sampling, population and sample size, measures, cortisol data collection method, sample characteristics, and results. Any discrepancies were resolved by consensus between the two reviewers.
Risk of Bias in Individual Studies
The methodological and reporting quality of each study was appraised by a single reviewer and checked by a second reviewer using the Joanna Briggs Institute Meta Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI; descriptive and case control studies; JBI, 2011). Discrepancies were resolved by consensus.
Summary Measures
Due to the heterogeneity of the studies retrieved, a narrative synthesis was conducted to present the results of the studies. Among studies that reported means and standard deviations/errors or inferential statistics, we calculated standardized mean difference (Cohen's d) effect sizes, respectively, for each of those studies to quantify the associations between cortisol with PTSD (Cohen, 1988) .
Results
Selection of Studies
The initial search yielded 412 articles. After application of the exclusion criteria and elimination of duplicates, 20 articles were retained for further screening. Among the 20 articles, 6 studies that included both female and male participants and did not conduct analysis for female participants only and 1 study focusing on all types of trauma were excluded. In the end, 13 studies were included in the review. All were published between 1995 and 2012. Among the 13 studies reviewed, 10 studies reported means and standard deviations/errors or inferential statistics and, thus, we computed effect sizes for each of those 10 studies (Altemus, Cloitre, & Dhabhar, 2003; Bremner, Vermetten, & Kelley, 2007; Bremner, Vythilingam, Anderson, et al., 2003; Elzinga, Schmahl, Vermetten, van Dyck, & Bremner, 2003; Lemieux, Coe, & Carnes, 2008; Lemieux & Coe, 1995; Newport, Heim, Bonsall, Miller, & Nemeroff, 2004; Pace et al., 2012; Stein, Yehuda, Koverola, & Hanna, 1997) . The other three studies did not provide any statistics that could be used to calculate effect sizes, and thus a narrative synthesis was used for these three studies (Brand et al., 2010; Heim et al., 2002; Nicolson, Davis, Kruszewski, & Zautra, 2010) . A flow chart detailing the identification of studies is shown in Figure 1 .
Study Description
Study Quality and Comparison Groups. The 13 studies met three or four criteria of the seven JBI-MAStARI quality criteria. Most of the study designs (12 studies) were case control except for one descriptive study (Brand et al., 2010) . With relatively small convenience samples ranging from 11 to 23, 9 studies had a group with both PTSD and CMT exposure. Among them, five studies used non-PTSD groups with and without histories of CMT as two comparison groups (Bremner et al., 2007; Bremner, Vythilingam, Anderson, et al., 2003; Lemieux et al., 2008; Lemieux & Coe, 1995; Newport et al., 2004) . One study only used non-PTSD group with CMT (Elzinga et al., 2003) , and three studies only used non-PTSD group without CMT (Altemus et al., 2003; Pace et al., 2012) for comparison. The range of sample sizes were 8 to 14 for non-PTSD group with CMT and 9 to 24 for non-PTSD group without CMT. The other four studies did not have a PTSD group, but they measured PTSD symptoms, analyzed the relationship between PTSD and cortisol, and at the same time controlled for CMT in analyses. One study included women with and without a history of CMT (Stein et al., 1997) ; one study included women who experienced CMT with and without current major depression (MDD), women with MDD but no CMT, and healthy controls (Heim et al., 2002) ; one study enrolled women with osteoarthritis and fibromyalgia syndrome (Nicolson et al., 2010) ; and one study included women at 6 months postpartum (Brand et al., 2010) . The total sample size ranges from 40 to 126 for those four studies. Although only one study matched the participants in terms of age, gender, or race (Altemus et al., 2003) , other studies either demonstrated no significant differences between groups on the demographic factors or controlled for them in the statistical analysis section. In 12 studies, all subjects were women. The 13th study included both women and men, but did separate analyses for female and male participants .
Measures. To assess PTSD, standardized interviews such as the Structured Clinical Interview for DSM-IV (American Psychiatric Association, 1994), the Clinician-Administered PTSD Scale (Blake et al., 1995) , the Munich-Composite International Diagnostic Interview (Wittchen, Lachner, Wunderlich, & Pfister, 1998) , the National Institute of Mental Health Diagnostic Interview Schedule (Marcus, Robins, & Bucholz, 1991) , and the Semi-Structured Assessment for the Genetics of Alcoholism-II (Bucholz et al., 1994) were described in almost all studies. Only one study used a checklist based on the DSM-III-R criteria for PTSD to measure PTSD (Lemieux & Coe, 1995) . CMT was assessed using self-report questionnaires including the Early Trauma Inventory (Bremner, Vermetten, & Mazure, 2000) and the Childhood Trauma Questionnaire (Bernstein et al., 2003) or via selfreporting CMT experiences. The Early Trauma Inventory assesses physical abuse (e.g., slapped in the face, punched or kicked, pushed or shoved), emotional abuse (e.g., often put down or ridiculed, most of the time treated in cold or uncaring way, parents fail to understand your needs), and sexual abuse (e.g., touched in intimate parts in way that was uncomfortable, someone rubbing genitals against you, forced to touch intimate parts), as well as general traumatic events (e.g., serious accidents, serious personal injury, witnessing violence) prior to 18 years of age. The Childhood Trauma Questionnaire measures five different types of CMT including emotional abuse (e.g., parents wished was never born, felt hated by family, family said hurtful things), physical abuse (e.g., hit hard enough to see doctors, punished with hard objects, hit badly enough to be noticed), sexual abuse (e.g., touched sexually, molested, made to do sexual things), emotional neglect (e.g., not felt loved, not felt important, not looked out for), and physical neglect (e.g., not enough to eat, wore dirty clothes, not taken care of). Among four studies without screening tools, two studies focused on childhood sexual abuse only and they defined it as any unwanted sexual contact before the age of 18 years either within or outside the home, or attempted or completed vaginal or anal penetration before 14 years by a perpetrator who was at least 5 years older than the victim (Lemieux et al., 2008; Stein et al., 1997) , whereas the other two studies did not report the definitions of CMT (Altemus et al., 2003; Lemieux & Coe, 1995) .
Cortisol Sources. Cortisol was assessed in plasma/serum (Bremner et al., 2007; Bremner, Vythilingam, Anderson, et al., 2003; Heim et al., 2002; Newport et al., 2004; Pace et al., 2012; Stein et al., 1997) , saliva (Brand et al., 2010; Elzinga et al., 2003; Nicolson et al., 2010) , or 24-hour urinary free samples (Lemieux et al., 2008; Lemieux & Coe, 1995) , or a combination of two types of assessment (plasma and saliva; Altemus et al., 2003) . Assessment of cortisol under basal conditions involves examination of either diurnal pattern or the early morning peak (seven studies; Altemus et al., 2003; Bremner et al., 2007; Bremner, Vythilingam, Anderson, et al., 2003; Lemieux et al., 2008; Lemieux & Coe, 1995; Nicolson et al., 2010; Pace et al., 2012) . The remaining six studies assessed cortisol levels in response to the dexamethasone suppression test (DST; Newport et al., 2004; Stein et al., 1997) and other challenges (i.e., the cognitive challenge test, the trauma scripts exposure, psychosocial stress test, the mother-infant separation stressor and noise and arm stressor; Brand et al., 2010; Elzinga et al., 2003; Heim et al., 2002) . The DST involves nighttime oral administration (0.5 or 1 mg around 11 p.m.) of the dexamethasone (DEX) and the subsequent assessment of cortisol levels the following day (8 a.m., 4 p.m., and/or 11 p.m.).
Confounding Factors. Potential confounding factors varied greatly across studies. Participant exclusion, group comparison and adjustment in analyses, and group match were used to eliminate the influence of confounders. Three studies did not have exclusion criteria (Bremner et al., 2007; Heim et al., 2002; Lemieux & Coe, 1995) . Exclusion criteria varied across the other 10 studies, including head injury, neurological disorders (i.e., seizure), autoimmune disease (i.e., psoriasis, atopic dermatitis), serious medical disorders, organic mental disorders, psychotic disorder (i.e., schizophrenia), bipolar disorder, eating disorder, corticosteroids use, current psychotropic or hormonal medications, any medication with immunemodulating effects, and alcohol or substance abuse or dependence, regular use of alcohol or tobacco, obesity, pregnancy, and lactation. One study matched groups for age, race, and menstrual cycle phase or menopausal status (Altemus et al., 2003) , whereas some other studies compared group differences and reported no significant differences in terms of some sociodemographic characteristics (i.e., age, race, income, or education) or weight/ BMI. A few studies either controlled for comorbid depression or reported no effects of comorbid depression, medication use, or alcohol or substance abuse on cortisol levels in analyses (Altemus et al., 2003; Bremner, Vythilingam, Anderson, et al., 2003; Lemieux & Coe, 1995) .
Research Question Findings
Effect Sizes for Basal Cortisol Levels. We calculated effect sizes, respectively, for 10 studies (Table 1) . Six studies measured basal cortisol levels. In women with PTSD and CMT compared with either CMT only or healthy controls, one study found higher overall urinary 24-hour cortisol levels (all Cohen's d = 1.21; Lemieux & Coe, 1995) , whereas the other study by the same research team reported lower urinary cortisol levels (Cohen's d range: −1.87 to 2.23; Lemieux et al., 2008) . Two studies reported lower afternoon plasma levels in women with PTSD and CMT compared with either women with CMT only or healthy controls (Cohen's d range: −0.77 to 1.00; Bremner et al., 2007; Bremner, Vythilingam, Anderson, et al., 2003) . Effect sizes calculated from the four studies were large based on the suggestion by Cohen (1988) . The other two studies found no significant differences in plasma daytime or morning single-time cortisol levels between women with PTSD and CMT and healthy controls (Altemus et al., 2003; Pace et al., 2012) .
Effect Sizes for Challenged Cortisol Levels. Four studies measured challenged cortisol levels. In the two studies using the psychosocial stress test, no significant differences were detected between women with PTSD and CMT and either CMT only or healthy controls Elzinga et al., 2003) . The other two studies, which measured cortisol reactivity in response to the DEX administration, found no significant differences in cortisol levels after 1 mg DEX between women with PTSD and CMT and CMT only or healthy controls (Newport et al., 2004; Stein et al., 1997) . However, one of the two studies reported higher cortisol levels after 0.5 mg DEX in women with PTSD and CMT compared with healthy controls (Cohen's d = 1.23 for post-DST 8 a.m., Cohen's d = 0.69 for post-DST 4 p.m.; Newport et al., 2004) . The effect sizes were medium to high based on the suggestion by Cohen (1988) .
Narrative Synthesis of Findings From Studies Without Effect
Sizes Calculated. The other three studies did not provide any statistics that could be used to calculate effect sizes. Those three studies reported no significant associations between PTSD and basal salivary cortisol levels (Nicolson et al., 2010) or plasma or salivary cortisol levels in response to a psychosocial stress test after controlling for CMT (Brand et al., 2010; Heim et al., 2002) .
Discussion
This review was conducted systematically using the Joanna Briggs Institute Critical Appraisal Checklist for Systematic Reviews and Research Synthesis (JBI, 2011) . In this review, 13 studies were included to examine the patterns of cortisol levels in maltreated women with PTSD and to test the association between cortisol and PTSD after controlling for CMT exposure. Despite limiting focus to 13 studies that include the same gender (female), type of trauma (maltreatment) and timing of trauma (childhood), the patterns of associations between PTSD and cortisol levels were still inconsistent. Either lower or higher basal cortisol daily output in maltreated women with PTSD relative to healthy controls or no significances between groups were reported. Maltreated women with PTSD reported either lower or higher basal cortisol daily output compared with those with CMT exposure only. But two studies consistently found lower basal afternoon cortisol levels in women with PTSD who experienced CMT relative to CMT only or healthy controls (Bremner et al., 2007; Bremner, Vythilingam, Anderson, et al., 2003) . No differences between groups were found in cortisol levels in response to the psychosocial stress tests or the standarddose DEX (1 mg), whereas one of the studies reported higher levels after the low-dose DEX (0.5 mg) in maltreated women with PTSD compared with healthy controls (Newport et al., 2004) . In studies with significant findings, the effect sizes were large. (22) NA (14) NA ( Cohen's d was calculated for cortisol levels after the low dose DEX and no significance was detected for the standard dose. The other three studies were not shown in the table because means and standard deviations/errors or inferential statistics are not available. *p < .05.
Higher, lower, or similar basal daily output in maltreated women with PTSD compared with healthy women and higher or lower levels in maltreated women with PTSD compared with those with CMT only were reported in reviewed studies. One interpretation of the inconsistencies is that study methods are still too diverse, with different sample characteristics, inclusion and exclusion criteria, protocols, cortisol sources, and assays. Restrictions regarding comorbid psychiatric disorders (e.g., depression, generalized anxiety disorder), alcohol or substance abuse, or psychotropic medication usage varied widely across studies. The sample characteristics (e.g., age, race, income, education) and cortisol sources (e.g., salivary, plasma, or urinary sample) differed as well. In some studies there may have been additional trauma exposures, and these were not always measured or controlled for in analysis, which may also influence the association between CMT and PTSD with cortisol and contribute to the inconsistent findings. An alternative explanation is the small convenience samples. The sample sizes of each group in reviewed studies are small, leading to low reliability of findings. Furthermore, because of the convenience sampling, the findings may not be generalized to the female population.
Despite the inconsistent findings in terms of basal daily output, two studies consistently found significantly lower plasma concentrations of cortisol in the afternoon as well as no differences in the morning in women with PTSD who experienced CMT compared with either those with CMT only or healthy controls (Bremner et al., 2007; Bremner, Vythilingam, Anderson, et al., 2003) . The findings were supported by a meta-analysis that found no significant differences in basal cortisol daily output between 828 individuals with PTSD and 800 controls across 37 studies but PTSD was associated with a trend lower afternoon cortisol (Meewisse et al., 2007) . Taken together, the basal cortisol pattern in maltreated women with PTSD and the association between basal cortisol daily output and PTSD controlling for the influence of CMT are still controversial, though women with PTSD who experienced CMT are likely to have lower afternoon cortisol levels and similar morning levels compared with those with CMT only or healthy women.
No differences in cortisol levels in response to the psychosocial stress tests or the standard-dose DEX were found in reviewed studies except one study reporting higher levels after the low-dose DEX (Newport et al., 2004) , which may suggest that maltreated women with PTSD do not differ from women with CMT only or healthy women in terms of the stress reactivity of the HPA axis and the sensitivity of the HPA axis to negative feedback. Two meta-analyses found elevated HPA feedback function in relation to trauma-exposure status, indicating that enhanced HPA axis feedback function might be a marker of trauma-exposure rather than a specific mechanism of vulnerability for PTSD (Klaassens et al., 2012; Morris et al., 2012) . The nonsignificant findings may be also because of the small convenience sample. Future studies with large sample size are needed to examine the challenged cortisol concentrations in maltreated women with PTSD.
Another potentially important interpretation for the heterogeneous findings is that unmeasured stress response hormones, particularly those implicated in Cascade theory (i.e., oxytocin, catecholamines; Teicher et al., 2002) may be stronger, more consistent primary mediators of the morbidity associated with PTSD. Catecholamines, for example, including epinephrine and norepinephrine have been studied in relation to PTSD (Delahanty, Nugent, Christopher, & Walsh, 2005; Yehuda, Southwick, Giller, Ma, & Mason, 1992) . Oxytocin also has received increasing attention for its role in stress regulation and related psychopathology, including PTSD (Olff, Langeland, Witteveen, & Denys, 2010) . The oxytocin and HPA systems are mutually regulated (Dabrowiska et al., 2011) . If the HPA axis (sympathetic) function changes, the oxytocin (parasympathetic) system function may change as well. Therefore, it seems possible that cortisol interacts with other biomarkers to contribute to the morbidity associated with PTSD and that these could have stronger or more consistent patterns.
Across the 13 studies, cortisol sources were varied. Basal cortisol levels were measured via collecting 24-hour urine sample and salivary or blood sample at multiple times or a single time in a day. Challenged cortisol levels were measured via collecting salivary or plasma sample in response to pharmacological and psychological challenges. The 24-hour urine sample reflects overall daily cortisol production. The salivary or blood sample at specific times reflects HPA activity in the past 10 to 60 minutes and the sample collected at multiple times throughout the day reflects daily cortisol output or diurnal cortisol patterns. Cortisol response to the DST and psychological stress tests indicate the sensitivity of the HPA axis to negative feedback and reactivity of the HPA axis to stress (Handwerger, 2009) . Each cortisol measure has well-recognized advantages and disadvantages (Levine, Zagoory-Sharon, Feldman, Lewis, & Weller, 2007) . For example, sampling cortisol from saliva is frequent, rapid, and noninvasive, whereas the problems of saliva sampling are subject compliance and insufficient saliva. It is unclear which cortisol measurement is most reliable to reflect HPA axis function. Future studies need to examine the optimal cortisol measures and implement standard data collection and sampling protocol when sampling cortisol from saliva, blood, or urine.
Covariate accounting is also varied across the reviewed studies, making it difficult to compare findings across studies. The review article by (Stalder et al., 2016) summarized confounding factors and suggested strategies of dealing with those confounders, which could be considered as a guideline for future cortisol studies. Consensus guideline in future research will yield more reliable findings, facilitate comparison of data across studies, and thus contribute to more consistent conclusions. Stalder et al. (2016) also recommended that female characteristics such as oral contraceptives, menstrual cycle, or pregnancy status needed to be assessed and accounted for. Only one study reviewed matched groups for menstrual cycle (Altemus et al., 2003) and one study excluded pregnant women (Newport et al., 2004) . Future studies examining cortisol levels in female population should take into account the effects of oral contraceptives, menstrual cycle, or pregnancy status.
This literature review had some limitations. First, since unpublished studies were not included, publication bias might have obscured the results, as studies with significant results are more likely to be published. Second, studies included in the review have the limitation of having relatively small convenience samples, which increases the risk for selection bias and might also contribute to the inconsistent findings. Third, the literature reviewed focused only on cortisol as a biomarker of PTSD in women who experienced CMT. Since biomarkers from multiple biological systems are interconnected with each other, focusing on cortisol alone may not fully elucidate the associations with PTSD. Last, limiting our focus to studies that include the female population and maltreatment experiences in childhood resulted in a small number of studies analyzed in this review.
Conclusions
Given the varied findings on cortisol daily output and the small number of reviewed studies with small convenience sample sizes, it is difficult to draw conclusions about the patterns of cortisol levels, whether at rest, or in response to HPA axis suppression or stimulation test, in women with CMT history and PTSD. Future studies using similar study methods (e.g., data collection, sample characteristics, and confounding factors) are needed to facilitate comparison of data across studies. From another perspective, these findings may suggest stress-response hormones other than cortisol that may be more significant biomarkers of PTSD or may interact with cortisol on the morbidity associated with PTSD. One promising avenue for improving our understanding could be to increase attention to complexity in the stress responses. Increasing attention to multiple stress hormones may improve the ability to understand the effects of traumatic stress and/or PTSD on women's health outcomes. Understanding the physiology of CMT-related PTSD could underpin bio-behavioral interventions.
